- Home
- GEVO vs ALMS Comparison
GEVO vs ALMS Comparison
Compare GEVO & ALMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GEVO
- ALMS
- Stock Information
- Founded
- GEVO 2005
- ALMS 2021
- Country
- GEVO United States
- ALMS United States
- Employees
- GEVO N/A
- ALMS N/A
- Industry
- GEVO Major Chemicals
- ALMS
- Sector
- GEVO Industrials
- ALMS
- Exchange
- GEVO Nasdaq
- ALMS NYSE
- Market Cap
- GEVO 749.5M
- ALMS 652.3M
- IPO Year
- GEVO 2011
- ALMS 2024
- Fundamental
- Price
- GEVO $1.43
- ALMS $8.85
- Analyst Decision
- GEVO Strong Buy
- ALMS Strong Buy
- Analyst Count
- GEVO 3
- ALMS 6
- Target Price
- GEVO $6.48
- ALMS $29.60
- AVG Volume (30 Days)
- GEVO 9.3M
- ALMS 78.8K
- Earning Date
- GEVO 11-07-2024
- ALMS 11-13-2024
- Dividend Yield
- GEVO N/A
- ALMS N/A
- EPS Growth
- GEVO N/A
- ALMS N/A
- EPS
- GEVO N/A
- ALMS N/A
- Revenue
- GEVO $15,589,000.00
- ALMS N/A
- Revenue This Year
- GEVO $18.65
- ALMS N/A
- Revenue Next Year
- GEVO $56.15
- ALMS N/A
- P/E Ratio
- GEVO N/A
- ALMS N/A
- Revenue Growth
- GEVO 16.59
- ALMS N/A
- 52 Week Low
- GEVO $0.48
- ALMS $8.23
- 52 Week High
- GEVO $3.39
- ALMS $13.53
- Technical
- Relative Strength Index (RSI)
- GEVO 36.21
- ALMS N/A
- Support Level
- GEVO $1.41
- ALMS N/A
- Resistance Level
- GEVO $1.72
- ALMS N/A
- Average True Range (ATR)
- GEVO 0.23
- ALMS 0.00
- MACD
- GEVO -0.15
- ALMS 0.00
- Stochastic Oscillator
- GEVO 1.96
- ALMS 0.00
About GEVO Gevo Inc.
Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. Its operating segments are the Gevo segment, Renewable Natural Gas Segment, and the Agri-Energy segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure.
About ALMS ALUMIS INC
Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies.